BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moreira-de-Sá A, Lourenço VS, Canas PM, Cunha RA. Adenosine A2A Receptors as Biomarkers of Brain Diseases. Front Neurosci 2021;15:702581. [PMID: 34335174 DOI: 10.3389/fnins.2021.702581] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Franco R, Lillo A, Navarro G, Reyes-resina I. The adenosine A2A receptor is a therapeutic target in neurological, heart and oncogenic diseases. Expert Opinion on Therapeutic Targets 2022. [DOI: 10.1080/14728222.2022.2136570] [Reference Citation Analysis]
2 Rahman MM, Islam MR, Mim SA, Sultana N, Chellappan DK, Dua K, Kamal MA, Sharma R, Emran TB, Ciobica A. Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation. Oxidative Medicine and Cellular Longevity 2022;2022:1-22. [DOI: 10.1155/2022/8425640] [Reference Citation Analysis]
3 Luo J, Chen D, Qin B, Kong D. Molecular mechanisms for the prevention and promoting the recovery from ischemic stroke by nutraceutical laminarin: A comparative transcriptomic approach. Front Nutr 2022;9:999426. [DOI: 10.3389/fnut.2022.999426] [Reference Citation Analysis]
4 Zhang S, Li B, Tang L, Tong M, Jiang N, Gu X, Zhang Y, Ge Y, Liu X, Chen J. Disruption of CD73-Derived and Equilibrative Nucleoside Transporter 1–Mediated Adenosine Signaling Exacerbates Oxygen-Induced Retinopathy. The American Journal of Pathology 2022. [DOI: 10.1016/j.ajpath.2022.07.014] [Reference Citation Analysis]
5 Kruyer A, Kalivas PW, Scofield MD. Astrocyte regulation of synaptic signaling in psychiatric disorders. Neuropsychopharmacol . [DOI: 10.1038/s41386-022-01338-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Sun C, Wang B, Hao S. Adenosine-A2A Receptor Pathway in Cancer Immunotherapy. Front Immunol 2022;13:837230. [PMID: 35386701 DOI: 10.3389/fimmu.2022.837230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Merighi S, Borea PA, Varani K, Vincenzi F, Jacobson KA, Gessi S. A(2A) Adenosine Receptor Antagonists in Neurodegenerative Diseases. Curr Med Chem 2022;29:4138-51. [PMID: 34844537 DOI: 10.2174/0929867328666211129122550] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]